Top Dermatologic Toxicities from Cancer Therapy: Prevention and Early Intervention
-
Register
- Non-member - Free!
- Member - Free!
Learning Objectives:
- Recognize common dermatologic toxicities in patients receiving anti-cancer therapy
- Understand the importance of dermatologic toxicities and the impact on patients’ quality of life and treatment adherence
- Describe evidence-based prevention and management strategies for skin-related adverse effects
- Illustrate the role of advanced practice providers in monitoring, prevention, and patient education of dermatologic toxicities
- Understand best practices for patient reporting of negative skin outcomes
This event was sponsored by Johnson & Johnson
Megan Bielawa, DMSc, MS, PA-C
Memorial Sloan Kettering Cancer Center
Megan Bielawa is a board-certified physician assistant specializing in dermatology. She has been working in the field of dermatology for 7 years and specifically in oncodermatology for the past 5 years at Memorial Sloan Kettering Cancer Center in Hauppauge. She serves as a guest lecturer for the Hofstra University Physician Assistant Studies program where she developed the Dermatology for Patients of Color curriculum. She also serves as a mentor and clinical preceptor for PA students.
Cara Norelli, MS, AGNP-C
Memorial Sloan Kettering Cancer Center
Cara Norelli is a board-certified adult nurse practitioner with 8 years of dermatology experience and is currently specializing in Oncodermatology at Memorial Sloan Kettering Cancer Center in Manhattan. She is compassionate about treating conditions related to various cancer therapies including rashes, hair changes and cancerous wounds.
Key:
Complete
Next
Failed
Available
Locked
